31st Clinical Applications for Age Management Medicine Conference On-Demand

19 CME Credits – $645.00

This On-Demand Conference covers Age Management Medicine focused topics and advanced strategies that fill educational gaps and target the hottest topics and challenges impacting 21st-century medical practices. You will be introduced to the latest science-based clinical information and sophisticated clinical applications.

This conference is guaranteed to impact your medical practice—from enhancing your knowledge and performance levels to increasing your practice’s value with healthier, better outcomes.

After attending this in-depth conference you’ll walk away with what you need to add this 21st-century medical specialty to your existing practice, or expand you current Age Management Medicine Practice. We’ll even show you how you can become Certified in Age Management Medicine.

CME Information

“In support of improving patient care, this activity has been planned and implemented with Foundation for Care Management and Age Management Medicine Group.

Foundation for Care Management is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.”

AMA PRA Category 1 Statement:

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Foundation for Care Management (FCM) and Age Management Medicine Group.  The Foundation for Care Management is accredited by the ACCME to provide continuing medical education for physicians.

FMC designates this educational activity for a maximum of 26 AMA PRA Category 1 CreditsTM.  Physicians should only claim credit commensurate with the extent of their participation in this activity.

The ACCME defines an ineligible company(s) as those whose primary business is producing, marketing, selling, reselling, or distributing healthcare products used by or on patients.

Nursing Statement:

Foundation for Care Management is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Foundation for Care Management has designated this activity as approved for up to 26 hours of nursing continuing professional development.

Disclosure Statements

Planning Committee: All AMMG Planning Committee members

Faculty Disclosures: All AMMG Planning Committee members

Program Reviewers: Mary Corry, MSN and Dana Burnett, M. Ed. have no relevant financial relationships to disclose.

All relevant financial relationships for this event have been reviewed and mitigated.

Conflict of Interest Disclosure Policy
Identify, Mitigate, and Disclose Relevant Financial Relationships.

Many healthcare professionals have financial relationships with ineligible companies.  These relationships must not be allowed to influence accredited continuing education.

The Foundation for Care Management (FCM) as the accredited provider is responsible for identifying relevant financial relationships between individuals in control of educational content and ineligible companies and managing these to ensure they do not introduce commercial bias into the education.  Financial relationships are defined as relevant if the educational content is related to the business lines or products of the ineligible company.  As an accredited provider FCM collects information from planners, faculty and other in control of educational content and conducts an extensive review process.  Financial relationships are identified, reviewed and mitigated.  In some cases, speakers and committee members may be excluded.  All relevant financial relationships are disclosed to learners in this handout as required by the ACCME.

Faculty/Planner Disclosures

Conference Planning Committee
Florence Comite, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Mary L. Corry, R.N. – No Relevant Relationships with a Commercial Interest to Disclose
Mark L. Gordon, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Rob A. Kominiarek, D.O. – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John Rush, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
George Shapiro, M.D. – No Relevant Relationships with a Commercial Interest to Disclose

Faculty
Christopher Arboleda, MS – No Relevant Relationships with a Commercial Interest to Disclose
Michale Barber, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
John C. Carrozzella, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
William Clearfield, D.O.  – No Relevant Relationships with a Commercial Interest to Disclose
Florence Comite, M.D.  – No Relevant Relationships with a Commercial Interest to Disclose
Dana Delgardo, FNP – No Relevant Relationships with a Commercial Interest to Disclose
Carolyn DeLucia, M.D.  – No Relevant Relationships with a Commercial Interest to Disclose
Angela DeRosa, D.O. –  Belmar Pharma, Medical Director; Hormone Health Institute, Owner/ Founder
Derrick DeSilva, Jr., M.D.  – No Relevant Relationships with a Commercial Interest to Disclose
Elliott Dinetz, M.D.  – No Relevant Relationships with a Commercial Interest to Disclose
Benjamin Gonzalez, M.D.  – No Relevant Relationships with a Commercial Interest to Disclose
Jonathan Keith, M.D., FACS – No Relevant Relationships with a Commercial Interest to Disclose
Dobri Kiprov, M.D. –  Fresenius Medical Care, Stock or Stock Options
Edwin N. Lee, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Jeffry Life, M.D., Ph.D.  – No Relevant Relationships with a Commercial Interest to Disclose
Ashley Madison –  No Relevant Relationships with a Commercial Interest to Disclose
Luis Martinez, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Kathy Maupin, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Abraham Morgenthaler, M.D.  – Antares, Consultant; Acerus, Consultant; Bayer, Advisory Committee Member; Marius, Consultant; Endo, Research Gran
Beatriz Olsen, M.D., FACP – No Relevant Relationships with a Commercial Interest to Disclose
Cesar M. Pellerano, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Theresa Ramsey, NMD – No Relevant Relationships with a Commercial Interest to Disclose
Neal Rouzier, M.D. – Evexias, Speaker Bureau
Jodie Scholes – Green Sunshine, Ownership
Jin-Xiong She, Ph.D. –  Jinfiniti Precision Medicine, Executive Role/Ownership
Jason Sonners, D.C., DCBCN – No Relevant Relationships with a Commercial Interest to Disclose
Paul Thompson, M.D. – Launch Medical, Executive Role, Organicel, Stock Options
Dushyant Viswanathan, M.D. – No Relevant Relationships with a Commercial Interest to Disclose
Payam Zand, M.D. – No Relevant Relationships with a Commercial Interest to Disclose

Release Date: January 10, 2022
Expiration Date: January 10, 2023

  1. Describe the essential scientific evidence-based information for the use of approved Hormones in Age Management Medicine and how to critically apply this knowledge to individualized treatment plans to improve patient outcomes.
  2. Describe and discuss issues which occur related to Hormone Therapy such as the use of Natural Aromatase Inhibitors effects of Testosterone on Prostate Cancer and Post Finasteride Syndrome.
  3. Describe evidence-based information for the diagnosis and treatment of Traumatic Brain Injury and how to clinically apply this knowledge to individualized patient treatment plans and summarize the available scientific literature discussing the primary traumas and secondary effects of inflammation in patient with TBI.
  4. Explain evidence-based information on Precision Medicine applications such as Epigenetic Methylation, Epigenetics and implications for Cardiovascular Disease, and Stem Cell Therapy for Immune System Restoration.
  5. Compare and discuss essential scientific evidence-based information on the use of Food and Medicine and various approaches to diet and nutrition in an effort to provide for superior patient outcomes.
  6. Discuss new scientific evidenced-based information for disease prevention and intervention, specifically for COVID-19 and how to clinically apply this knowledge to individualized patient treatment plans to improve patient outcomes.

Instructions for Obtaining CME Credit

Completing all steps is a requirement in order to qualify for your CME and to receive your CME certificate.

  1. Review the Accreditation & Faculty Disclosures.
  2. Watch ALL videos on the lesson page.
  3. After watching the entire course take the Post-Test so we can determine the value of this course.
  4. After completing the Post-Test  “Click Here to Continue” and complete the entire Course Evaluation
  5. At the completion of the Course Evaluation you will be taken to a screen where you can immediately download and print a copy of your CME Certificate.
  • IMPORTANT: Do not exit the evaluation until you have completed it and downloaded your CME Certificate.
  • A copy will also be emailed to the address you used to sign up. If you don’t receive it immediately check your SPAM folder.
Buy this Course